This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (57)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Statistics and Research Methods  • Conflict of Interest  • Health Policy  • Medical Ethics  • Alert me on articles by topic

Catherine D. DeAngelis, MD, MPH

JAMA. 2000;284:2237-2238.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

This issue of THE JOURNAL contains a cluster of articles that address students', residents', and faculty members' conflicts of interest with pharmaceutical and other companies that financially sponsor teaching and research. Why is this important? University-based educators and researchers, as well as private practitioners, are in frequent contact with representatives from for-profit companies that provide "gifts" and financial support for teaching and research. The enticement begins very early in a physician's career: for my classmates and me, it started with black bags. Dr Kassirer's colleague¹ is not alone in remembering which pharmaceutical company provided them. The timing of presenting the black bags early in our first year was wonderfully strategic, as was the inscription of our names on each. I must admit I was very happy to finally have a real symbol of the medical profession after so many hours of what seemed like year . . . [Full Text of this Article]

Author Affiliation: Dr DeAngelis is Editor, JAMA.

RELATED ARTICLES

Financial Indigestion
Jerome P. Kassirer
JAMA. 2000;284(17):2156-2157.
EXTRACT | FULL TEXT  

Evaluation of HIV-1 Immunogen, an Immunologic Modifier, Administered to Patients Infected With HIV Having 300 to 549 x 10⁶/L CD4 Cell Counts: A Randomized Controlled Trial
James O. Kahn, Deborah Weng Cherng, Kenneth Mayer, Henry Murray, Stephen Lagakos, and for the 806 Investigator Team
JAMA. 2000;284(17):2193-2202.
ABSTRACT | FULL TEXT  

Policies on Faculty Conflicts of Interest at US Universities
Mildred K. Cho, Ryo Shohara, Anna Schissel, and Drummond Rennie
JAMA. 2000;284(17):2203-2208.
ABSTRACT | FULL TEXT  

Assessing Faculty Financial Relationships With Industry: A Case Study
Elizabeth A. Boyd and Lisa A. Bero
JAMA. 2000;284(17):2209-2214.
ABSTRACT | FULL TEXT  

Conflicts of Interest in Biomedical Research
David Korn
JAMA. 2000;284(17):2234-2237.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Passing the Headline Test
Reider
Am J Sports Med 2007;35:1807-1808.
FULL TEXT  

The Legal and Ethical Issues Surrounding Financial Conflict of Interest in Orthopaedic Research
Okike and Kocher
JBJS 2007;89:910-913.
FULL TEXT  

Regulating Academic-Industrial Research Relationships -- Solving Problems or Stifling Progress?
Stossel
NEJM 2005;353:1060-1065.
FULL TEXT  

Physician remuneration in industry-sponsored clinical trials: the case for standardized clinical trial budgets
Ferris and Naylor
CMAJ 2004;171:883-886.
FULL TEXT  

Rebuttal
Ferris and Naylor
CMAJ 2004;171:892-893.
FULL TEXT  

Publishing Commentary by Authors with Potential Conflicts of Interest: When, Why, and How
The Editors
ANN INTERN MED 2004;141:73-74.
FULL TEXT  

Assessing the Performance of a Medical Journal
Tobin
Am. J. Respir. Crit. Care Med. 2004;169:1268-1272.
FULL TEXT  

Currents in Contemporary Ethics
Caulfield et al.
J Law Med Ethics 2004;32:365-368.
 

Ethical Concerns in Industry Support of Continuing Medical Education: The Con Side
Packer and Parke
Arch Ophthalmol 2004;122:773-776.
FULL TEXT  

Industry Sponsorship and Authorship of Clinical Trials Over 20 Years
Buchkowsky and Jewesson
The Annals of Pharmacotherapy 2004;38:579-585.
ABSTRACT | FULL TEXT  

Media Coverage of Conflicts of Interest in Science
McComas and Simone
Science Communication 2003;24:395-419.
ABSTRACT  

Conflicts of Interest and AJRCCM: Restating Policy and a New Form to Upload
Tobin
Am. J. Respir. Crit. Care Med. 2003;167:1161-1164.
FULL TEXT  

Research fraud: Why nurses should become aware
Kenkre and Semple
Journal of Research in Nursing 2003;8:47-56.
ABSTRACT  

From Certainty to Uncertainty: The Story of Science and Ideas in the Twentieth Century
Satya-Murti
JAMA 2002;288:2477-2478.
FULL TEXT  

A National Survey of Provisions in Clinical-Trial Agreements between Medical Schools and Industry Sponsors
Schulman et al.
NEJM 2002;347:1335-1341.
ABSTRACT | FULL TEXT  

Partnerships Between Universities and Industry
Ehrle et al.
JAMA 2002;287:1398-1400.
FULL TEXT  

From Clinical Trial to Prescription
Carpenter
Arch Gen Psychiatry 2002;59:282-285.
ABSTRACT | FULL TEXT  

Medical Innovation and Institutional Interdependence: Rethinking University-Industry Connections
Gelijns and Thier
JAMA 2002;287:72-77.
ABSTRACT | FULL TEXT  

Legal Issues in Scientific Research
Kalb and Koehler
JAMA 2002;287:85-91.
ABSTRACT | FULL TEXT  

Dancing with the porcupine: rules for governing the university-industry relationship
Lewis et al.
CMAJ 2001;165:783-785.
FULL TEXT  

Reporting Financial Conflicts of Interest and Relationships Between Investigators and Research Sponsors
DeAngelis et al.
JAMA 2001;286:89-91.
FULL TEXT  

Academic Relationships With Industry: A New Model for Biomedical Research
Moses III and Martin
JAMA 2001;285:933-935.
FULL TEXT  

To Protect Those Who Serve
Drazen and Koski
NEJM 2000;343:1643-1645.
FULL TEXT